Skip to main content
. 2014 Dec 3;3:20. doi: 10.1186/s13737-014-0020-6

Table 3.

Results of univariate and multivariate Cox regression survival analyses of all RTRs; all-cause mortality ( N= 23) is the dependable variable

Variable Univariate analyses Multivariate analyses
HR 95% CI p HR 95% CI p
Time on waiting list (per year) 1.27 1.00-1.62 0.05* 1.62 1.07–1.78 0.02*
Creatinine (per 10 μmol/l) 1.03 1.01–1.06 0.01* 1.07 1.03–1.11 <0.001*
LVH 3.78 1.12–12.72 0.03* 6.23 1.18–22.31 0.004*
Male 0.43 0.19–0.98 0.04* 0.23 0.11–0.65 0.02*
LAV/BSA above 32.1 ml/m2 3.11 1.27–7.57 0.01* 6.60 1.70–18.58 0.02*
Delayed graft function 2.42 1.08–5.64 0.03 3.12 1.02–9.57 0.05*
Cerebrovascular disease 6.76 2.58–17.78 0.05* 3.12 0.91–23.7 0.07
Peripheral vascular disease 3.36 1.00–11.37 0.05* 7.38 0.51–52.3 0.21
Age at transplantation (per year) 1.04 1.00–1.08 0.05* 1.02 0.96–1.26 0.43
BMI (per kg/m2) 1.02 0.94–1.12 0.69
Biopsy-proven acute rejection 2.76 0.37–5.68 0.21
LVSD 2.38 0.88–6.47 0.08
Ischemic heart disease 1.33 0.45–3.91 0.61
LV dilation 1.16 0.34–3.90 0.82
Diabetes mellitus 0.59 0.25–1.31 0.19
Heart failure 0.86 0.12–6.40 0.88
Current/Ex smoker (ref never) 1.58 0.67–3.72 0.30
Systolic BP (per mmHg) 1.02 0.99–1.04 0.15
Diastolic BP (per mmHg) 0.98 0.94–1.02 0.26
Dyslipidemia 1.67 0.71–3.99 0.24
RRT time to CMR (years) 0.92 0.81–1.05 0.21
Previous RRT type
PD 1.00
HD 1.29 0.17–9.79 0.80
Hemoglobin (per g/dl) 0.65 0.97–1.13 0.13
Albumin (per g/l) 0.83 0.65–1.05 0.13
Phosphate (per mmol/l) 0.43 0.07–2.75 0.37
Calcium (per mmol/l) 5.45 0.11–12.54 0.40
ACEI/ARB therapy pre-transplant 0.52 0.16–1.76 0.29
ACEI/ARB therapy post-transplant 0.42 0.10–1.80 0.24

Hazard ratios (95% confidence intervals (CI)) are shown. Variables highlighted with (*) were added to the multivariate Cox model. Abbreviations: LV left ventricle, LVH left ventricular hypertrophy, LVSD left ventricular systolic dysfunction, BMI body mass index, BP blood pressure, RRT renal replacement therapy, PD peritoneal dialysis, HD hemodialysis. *p < 0.05